1. Home
  2. QUIK vs TNXP Comparison

QUIK vs TNXP Comparison

Compare QUIK & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$12.67

Market Cap

236.6M

Sector

Technology

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.64

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
TNXP
Founded
1988
2007
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.6M
199.7M
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
QUIK
TNXP
Price
$12.67
$12.64
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
292.3K
490.0K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
$20,112,000.00
$13,107,000.00
Revenue This Year
$75.17
$558.11
Revenue Next Year
$16.04
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$4.80
$9.40
52 Week High
$24.33
$53.55

Technical Indicators

Market Signals
Indicator
QUIK
TNXP
Relative Strength Index (RSI) 41.18 57.28
Support Level $11.76 $11.98
Resistance Level $14.81 $13.18
Average True Range (ATR) 0.95 0.86
MACD 0.13 0.25
Stochastic Oscillator 35.98 66.81

Price Performance

Historical Comparison
QUIK
TNXP

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: